Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | b-NGF | 55.5 | 60 | |
| RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | b-NGF | 54.0 | 54 | |
| RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | b-NGF | 43.0 | 54 | |
| N2586 | Visfatin | 1 | ng/mL | 1 | b-NGF | 73.0 | 43 | ||||
| N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | b-NGF | 83.0 | 35 | |
| N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | b-NGF | 64.0 | 63 | |
| N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | b-NGF | 83.0 | 57 | |
| N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | b-NGF | 71.0 | 30 | |
| N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | b-NGF | 69.0 | 39 | |
| 0 | b-NGF | 9.5 | 58 | ||||||||
| RA2159 | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 59.0 | 42 | ||||
| RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 74.0 | 60 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 47.0 | 29 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 67.0 | 73 | |
| RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 58.0 | 58 | |
| RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 31.0 | 77 | |
| N2586 | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 149.0 | 52 | ||||
| N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 177.0 | 31 | |
| N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 89.0 | 46 | |
| N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 117.0 | 46 | |
| N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 131.5 | 54 | |
| N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | b-NGF | 99.0 | 43 | |
| 0 | b-NGF | 8.0 | 50 | ||||||||
| RA2159 | 2 | b-NGF | 57.0 | 70 | |||||||
| RA2159 | EO1428 | 1.0 | uM | 2 | b-NGF | 45.0 | 51 |